Drug intelligence / Profile preview

Kurukshetra Univ. cathepsin B compound 6q

Development stage: Unknown
Lead developer: Kurukshetra University

Overview

Kurukshetra Univ. cathepsin B compound 6q: sourced facts only. name: "The in-vitro inhibition screening against cathepsin B revealed that most of the synthesized compounds are good competitive inhibitors (% inhibition = 22.91-75.04), with 6q (% inhibition = 75.04) and 6r (% inhibition = 71.13) as the eminent inhibitors of the series." [PMID:37634269]; target: "The in-vitro inhibition screening against cathepsin B revealed that most of the synthesized compounds are good competitive inhibitors (% inhibition = 22.91-75.04), with 6q (% inhibition = 75.04) and 6r (% inhibition = 71.13) as the eminent inhibitors of the series." [PMID:37634269]; developer: "Department of Chemistry, Kurukshetra University, Kurukshetra, Haryana, 136119, India." [PMID:37634269]

Targets

CTSB (Cathepsin B)

Beyond the preview

Go deeper on Kurukshetra Univ. cathepsin B compound 6q.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kurukshetra Univ. cathepsin B compound 6q.